Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$24.20 -1.0%	$28.17	$21.33 ▼ $40.49	$12.56B	0.59	10.31 million shs	7.71 million shs
PODD Insulet	$321.27 +1.7%	$298.40	$180.31 ▼ $329.33	$22.23B	1.35	695,485 shs	617,194 shs
RMD ResMed	$284.82 +0.0%	$264.17	$199.92 ▼ $293.08	$41.69B	0.77	1.18 million shs	1.01 million shs
WST West Pharmaceutical Services	$246.16 0.0%	$230.05	$187.43 ▼ $352.33	$17.70B	1.05	876,536 shs	781,012 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	-1.12%	+2.23%	-14.68%	-23.60%	-31.89%
PODD Insulet	+1.74%	+4.61%	+11.45%	-1.07%	+67.73%
RMD ResMed	+0.09%	+0.21%	+12.13%	+13.14%	+28.18%
WST West Pharmaceutical Services	-0.05%	+2.01%	+9.65%	+13.77%	-15.76%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BAX Baxter International	4.6953 of 5 stars	3.1	3.0	1.7	4.0	2.6	1.7	2.5
PODD Insulet	4.4022 of 5 stars	2.4	5.0	0.0	4.9	3.4	0.0	1.9
RMD ResMed	4.6537 of 5 stars	2.4	2.0	3.3	4.6	4.1	1.7	1.9
WST West Pharmaceutical Services	4.6988 of 5 stars	3.4	3.0	1.7	3.2	3.6	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAX Baxter International	2.20	Hold	$30.11	24.43% Upside
PODD Insulet	2.89	Moderate Buy	$330.71	2.94% Upside
RMD ResMed	2.81	Moderate Buy	$274.83	-3.51% Downside
WST West Pharmaceutical Services	2.89	Moderate Buy	$320.71	30.29% Upside

Current Analyst Ratings Breakdown

Latest WST, RMD, BAX, and PODD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/8/2025	PODD Insulet	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$331.00 ➝ $353.00
8/8/2025	PODD Insulet	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$330.00 ➝ $350.00
8/8/2025	PODD Insulet	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$330.00 ➝ $350.00
8/7/2025	PODD Insulet	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight
8/7/2025	PODD Insulet	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
8/4/2025	BAX Baxter International	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$41.00 ➝ $36.00
8/4/2025	BAX Baxter International	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$35.00 ➝ $24.00
8/4/2025	BAX Baxter International	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$36.00 ➝ $25.00
8/1/2025	BAX Baxter International	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$33.00 ➝ $24.00
8/1/2025	BAX Baxter International	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$25.00
8/1/2025	RMD ResMed	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAX Baxter International	$10.64B	1.17	$4.71 per share	5.14	$14.20 per share	1.70
PODD Insulet	$2.07B	10.92	$4.51 per share	71.18	$20.78 per share	15.46
RMD ResMed	$5.15B	8.10	$11.20 per share	25.42	$40.76 per share	6.99
WST West Pharmaceutical Services	$2.89B	6.12	$9.01 per share	27.32	$40.73 per share	6.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAX Baxter International	-$649M	-$0.30	N/A	8.86	0.80	-1.42%	16.96%	5.24%	N/A
PODD Insulet	$418.30M	$3.29	97.65	64.64	2.65	10.01%	23.78%	9.30%	N/A
RMD ResMed	$1.40B	$9.51	29.95	27.49	1.91	27.22%	25.62%	18.69%	10/23/2025 (Estimated)
WST West Pharmaceutical Services	$492.70M	$6.68	36.85	31.32	4.36	16.48%	18.43%	13.67%	10/23/2025 (Estimated)

Latest WST, RMD, BAX, and PODD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	PODD Insulet	$0.92	$1.17	+$0.25	$0.32	$612.31 million	$649.10 million
7/31/2025	Q2 2025	BAX Baxter International	$0.60	$0.59	-$0.01	$0.18	$2.82 billion	$2.81 billion
7/31/2025	Q4 2025	RMD ResMed	$2.47	$2.55	+$0.08	$2.58	$1.33 billion	$1.35 billion
7/24/2025	Q2 2025	WST West Pharmaceutical Services	$1.51	$1.84	+$0.33	$1.82	$725.11 million	$766.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAX Baxter International	$0.68	2.81%	N/A	N/A	N/A
PODD Insulet	N/A	N/A	N/A	N/A	N/A
RMD ResMed	$2.40	0.84%	N/A	25.24%	13 Years
WST West Pharmaceutical Services	$0.84	0.34%	N/A	12.57%	N/A

Latest WST, RMD, BAX, and PODD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/24/2025	WST West Pharmaceutical Services	quarterly	$0.22	0.39%	11/12/2025	11/12/2025	11/19/2025
7/14/2025	BAX Baxter International	quarterly	$0.17	2.38%	8/29/2025	8/29/2025	10/1/2025
7/31/2025	RMD ResMed	quarterly	$0.60	0.88%	8/13/2025	8/14/2025	9/18/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAX Baxter International	1.30	2.30	1.49
PODD Insulet	0.64	2.26	1.81
RMD ResMed	0.11	3.44	2.53
WST West Pharmaceutical Services	0.07	2.78	2.08

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAX Baxter International	90.19%
PODD Insulet	N/A
RMD ResMed	54.98%
WST West Pharmaceutical Services	93.90%

Insider Ownership

Company	Insider Ownership
BAX Baxter International	0.21%
PODD Insulet	0.39%
RMD ResMed	0.71%
WST West Pharmaceutical Services	0.53%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAX Baxter International	38,000	513.62 million	512.54 million	Optionable
PODD Insulet	3,900	70.39 million	70.12 million	Optionable
RMD ResMed	9,980	146.41 million	145.38 million	Optionable
WST West Pharmaceutical Services	10,600	71.91 million	71.53 million	Optionable

WST, RMD, BAX, and PODD Headlines

Recent News About These Companies

Wall Street Analysts See a 28.68% Upside in West Pharmaceutical (WST): Can the Stock Really Move This High?

August 15 at 10:55 AM | zacks.com

S Bank Fund Management Ltd Makes New $566,000 Investment in West Pharmaceutical Services, Inc. (NYSE:WST)

August 15 at 6:25 AM | marketbeat.com

Prudential PLC Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

August 15 at 5:54 AM | marketbeat.com

Nuveen LLC Makes New Investment in West Pharmaceutical Services, Inc. (NYSE:WST)

August 15 at 5:00 AM | marketbeat.com

Invesco Ltd. Has $212.56 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)

August 15 at 4:50 AM | marketbeat.com

Tokio Marine Asset Management Co. Ltd. Increases Position in West Pharmaceutical Services, Inc. (NYSE:WST)

August 14 at 7:17 AM | marketbeat.com

Mizuho Securities USA LLC Has $1.30 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)

August 14 at 4:41 AM | marketbeat.com

Citigroup Inc. Boosts Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

August 14 at 4:23 AM | marketbeat.com

West Pharmaceutical Services, Inc. (NYSE:WST) Stock Holdings Increased by LGT Group Foundation

August 13 at 7:22 AM | marketbeat.com

National Bank of Canada FI Has $12.38 Million Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

August 13 at 4:15 AM | marketbeat.com

Deutsche Bank AG Buys 42,536 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

August 13 at 3:45 AM | marketbeat.com

Charles Schwab Investment Management Inc. Has $110.11 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)

August 13 at 3:43 AM | marketbeat.com

Atria Wealth Solutions Inc. Buys 1,258 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

August 13 at 3:35 AM | marketbeat.com

Motley Fool Wealth Management LLC Buys Shares of 33,078 West Pharmaceutical Services, Inc. (NYSE:WST)

August 12, 2025 | marketbeat.com

Mitsubishi UFJ Asset Management Co. Ltd. Has $31.99 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST)

August 12, 2025 | marketbeat.com

4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks

August 11, 2025 | zacks.com

Vanguard Group Inc. Raises Position in West Pharmaceutical Services, Inc. (NYSE:WST)

August 11, 2025 | marketbeat.com

Cynosure Group LLC Has $2.38 Million Stake in West Pharmaceutical Services, Inc. (NYSE:WST)

August 10, 2025 | marketbeat.com

Townsquare Capital LLC Has $7.63 Million Stock Holdings in West Pharmaceutical Services, Inc. (NYSE:WST)

August 10, 2025 | marketbeat.com

Headlands Technologies LLC Purchases Shares of 2,061 West Pharmaceutical Services, Inc. (NYSE:WST)

August 10, 2025 | marketbeat.com

9,666 Shares in West Pharmaceutical Services, Inc. (NYSE:WST) Bought by ASR Vermogensbeheer N.V.

August 10, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST, RMD, BAX, and PODD Company Descriptions

Baxter International NYSE:BAX

$24.20 -0.25 (-1.02%)

Closing price 08/15/2025 03:58 PM Eastern

Extended Trading

$24.18 -0.02 (-0.08%)

As of 08/15/2025 07:56 PM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Insulet NASDAQ:PODD

$321.27 +5.49 (+1.74%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$322.07 +0.80 (+0.25%)

As of 08/15/2025 04:20 PM Eastern

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

ResMed NYSE:RMD

$284.82 +0.10 (+0.04%)

Closing price 08/15/2025 03:58 PM Eastern

Extended Trading

$285.04 +0.22 (+0.08%)

As of 08/15/2025 07:48 PM Eastern

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

West Pharmaceutical Services NYSE:WST

$246.16 -0.04 (-0.02%)

Closing price 08/15/2025 03:58 PM Eastern

Extended Trading

$245.06 -1.10 (-0.45%)

As of 08/15/2025 07:22 PM Eastern

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time